Attach to Form 990 or Form 990-EZ.
Information about Schedule A (Form 990 or 990-EZ) and its instructions is at www.irs.gov/form990.
| (i)Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 9 above or IRC section (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
| Total | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2010 | (b) 2011 | (c) 2012 | (d) 2013 | (e) 2014 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .... | 1,911,769 | 1,992,591 | 2,112,847 | 1,490,224 | 4,468,799 | 11,976,230 |
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf....... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | 1,911,769 | 1,992,591 | 2,112,847 | 1,490,224 | 4,468,799 | 11,976,230 |
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. | 6,506,127 | |||||
| 6 | Public support. Subtract line 5 from line 4. | 5,470,103 | |||||
Calendar year
(or fiscal year beginning in) ![]() |
(a) 2010 | (b) 2011 | (c) 2012 | (d) 2013 | (e) 2014 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | 1,911,769 | 1,992,591 | 2,112,847 | 1,490,224 | 4,468,799 | 11,976,230 |
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | 5,136 | 5,851 | 4,687 | 2,815 | 2,457 | 20,946 |
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support Add lines 7 through 10. | 11,997,176 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2010 | (b) 2011 | (c) 2012 | (d) 2013 | (e) 2014 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose...... | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513.. | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 6 | Total. Add lines 1 through 5. | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons... | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support (Subtract line 7c from line 6.) | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2010 | (b) 2011 | (c) 2012 | (d) 2013 | (e) 2014 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e | Discount claimed for blockage or other factors (explain in detail in Part VI): | |||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 1-1/2% of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by .035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| 7 | Check here if the current year is the organization's first as a non-functionally-integrated Type III supporting organization (see instructions) | |||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | ||
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
||
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | ||
| 4 Amounts paid to acquire exempt-use assets | ||
| 5 Qualified set-aside amounts (prior IRS approval required) | ||
| 6 Other distributions (describe in Part VI). See instructions | ||
| 7Total annual distributions. Add lines 1 through 6. | ||
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
||
| 9 Distributable amount for 2014 from Section C, line 6 | ||
| 10 Line 8 amount divided by Line 9 amount | ||
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2014 |
(iii) Distributable Amount for 2014 |
|
|---|---|---|---|---|
|
1
Distributable amount for 2014 from Section C, line 6 |
||||
|
2
Underdistributions, if any, for years prior to 2014 (reasonable cause required--see instructions) |
||||
| 3 Excess distributions carryover, if any, to 2014: | ||||
| a From 2009.......X | ||||
| b From 2010.......X | ||||
| c From 2011.......X | ||||
| d From 2012.......X | ||||
| e From 2013....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2014 distributable amount | ||||
|
i
Carryover from 2009 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from 3f. | ||||
| 4Distributions for 2014 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2014 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from 4. | ||||
|
5
Remaining underdistributions for years prior to 2014, if any. Subtract lines 3g and 4a from line 2 (if amount greater than zero, see instructions) |
||||
|
6
Remaining underdistributions for 2014. Subtract lines 3h and 4b from line 1 (if amount greater than zero, see instructions) |
||||
|
7 Excess distributions carryover to 2015. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a From 2010.......X | ||||
| b From 2011.......X | ||||
| c From 2012.......X | ||||
| d From 2013....... | ||||
| e From 2014....... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.
Information about Schedule O (Form 990 or 990-EZ) and its instructions is at| Return Reference | Explanation |
|---|---|
| FORM 990, PART III, LINE 1 | TAG WORKS TO ENSURE THAT ALL PEOPLE WITH HIV RECEIVE LIFESAVING TREATMENT, CARE, AND INFORMATION. WE ARE SCIENCE-BASED TREATMENT ACTIVISTS WORKING TO EXPAND AND ACCELERATE VITAL RESEARCH AND EFFECTIVE COMMUNITY ENGAGEMENT WITH RESEARCH AND POLICY INSTITUTIONS. TAG CATALYZES OPEN COLLECTIVE ACTION BY ALL AFFECTED COMMUNITIES, SCIENTISTS, AND POLICY MAKERS, AND GLOBAL COALITIONS, TO INCREASE THE QUANTITY, AND IMPROVE THE QUALITY OF RESEARCH, THAT CAN LEAD TO BETTER TB TREATMENT AND PREVENTION; PRECISE DIAGNOSTICS; AND PREVENTIVE VACCINES. |
| FORM 990, PART III, LINE 4A | TB/HIV PROJECT: TUBERCULOSIS (TB) KILLS ROUGHLY 1.3 MILLION PEOPLE EACH YEAR. DESPITE BEING CURABLE, IT IS THE LEADING CAUSE OF DEATH FOR HIV-POSITIVE PEOPLE GLOBALLY. HIV SIGNIFICANTLY INCREASES THE RISK FOR DEVELOPING TB DISEASE. PEOPLE AT RISK FOR BOTH DISEASES REQUIRE TB AND HIV SERVICES THAT WORK TOGETHER. TAG'S TB/HIV PROJECT STRENGTHENS COMMUNITY-DRIVEN ADVOCACY FOR BETTER TB/HIV RESEARCH, HIGH-QUALITY PROGRAMS, AND TB/HIV POLICIES WORLDWIDE. THE PROJECT EDUCATES, MOBILIZES, AND EMPOWERS HIV COMMUNITIES TO INCREASE COMMUNITY UNDERSTANDING OF TB/HIV COINFECTION AND TO TAKE ACTION TO REDUCE TB/HIV COINFECTION. THE PROJECT WORKS WITH RESEARCHERS, COMMUNITY ADVOCATES, POLICY MAKERS, AND GLOBAL COALITIONS, TO INCREASE THE QUANTITY, AND IMPROVE THE QUALITY OF RESEARCH, THAT CAN LEAD TO BETTER TB TREATMENT AND PREVENTION; PRECISE DIAGNOSTICS; AND PREVENTIVE VACCINES. |
| FORM 990, PART III, LINE 4B | HIV PROJECT: EACH DAY, NEARLY 4,000 PEOPLE WORLDWIDE DIE OF HIV DISEASE. THIS IMMENSE PUBLIC HEALTH FAILURE CAN BE ATTRIBUTED TO A DENSE WEB OF MEDICAL, POLITICAL, AND ECONOMIC PROBLEMS. THE VAST MAJORITY OF THE WORLD'S 35 MILLION HIV-POSITIVE PEOPLE LIVE IN POOR COUNTRIES WHERE MANY OBSTACLES PREVENT THE WIDESPREAD DISTRIBUTION OF HIV MEDICATIONS. BUT EVEN THE MOST EFFECTIVE EXISTING MEDICATIONS HAVE MAJOR SHORTCOMINGS, AND HIV-POSITIVE PEOPLE EVERYWHERE NEED BETTER TREATMENT STRATEGIES AND, ULTIMATELY, A CURE-ONE THAT IS SCALABLE, AFFORDABLE, AND CAN BE USED WORLDWIDE TO END THE EPIDEMIC, ALONG WITH A SAFE AND EFFECTIVE HIV VACCINE. TAG'S HIV PROJECT REVIEWS THE STATE OF RESEARCH ON ANTI-HIV TREATMENT, DEVELOPMENT, DISSEMINATION, AND POSTMARKETING SURVEILLANCE. THE HIV PROJECT ADVOCATES FOR ACCELERATED ACCESS TO TREATMENTS; INNOVATION IN THE DEVELOPMENT OF TREATMENTS THAT ARE ACTIVE AGAINST DRUG-RESISTANT HIV; AND DEVELOPMENT OF HIV TREATMENTS THAT ARE EASIER TO TAKE, LESS TOXIC, OR REPRESENT A MAJOR THERAPEUTIC BREAKTHROUGH, SUCH AS A NEW DRUG CLASS. THE PROJECT ADVOCATES FOR BETTER POSTMARKETING RESEARCH ON APPROVED ANTIRETROVIRAL DRUGS TO IMPROVE STANDARDS OF CARE; WORKS ON DOMESTIC AND INTERNATIONAL TREATMENT GUIDELINES; AND EDUCATES AND MOBILIZES POLICY MAKERS, RESEARCHERS, AND THE HIV COMMUNITY ON HIV TREATMENT RESEARCH. TAG'S HIV PROJECT WORKS WITH COMMUNITY MEMBERS, SCIENTISTS, AND POLICY MAKERS TO ENHANCE PUBLIC UNDERSTANDING OF THE SCIENCE OF HIV INFECTION, ADDRESS GAPS IN HIV RESEARCH, CRITIQUE RESEARCH EFFORTS, AND FOSTER CROSS-DISCIPLINARY COLLABORATIONS WITH THE AIM OF ACCELERATING RESEARCH ON HIV PATHOGENESIS AND THE DEVELOPMENT OF EFFECTIVE IMMUNE-BASED THERAPIES AND PREVENTIVE TECHNOLOGIES, WITH A PARTICULAR FOCUS ON RESEARCH ADVOCACY AROUND A CURE FOR HIV/AIDS. THE HIV PROJECT TRACKS AND ANALYZES RESOURCES DEVOTED TO HIV PREVENTION AND COMBINED PREVENTION TECHNOLOGIES. THE PROJECT ADVOCATES FOR LOCAL, STATE, AND NATIONAL AGENCIES AND AIDS SERVICE ORGANIZATIONS TO HAVE INCREASED AWARENESS OF CURRENT PREVENTION TOOLS IN ORDER TO STOP TRANSMISSION OF HIV AND THUS END THE EPIDEMIC. IN 2014, PROJECT MEMBERS WORKED ON GOVERNOR CUOMO'S TASK FORCE TO END AIDS IN NEW YORK STATE BY 2020. THIS EFFORT IS PART OF A BROADER PROJECT BY COMMUNITY ACTIVISTS, POLICY MAKERS, ADVOCATES, AND RESEARCHERS TO END THE EPIDEMIC BY STEMMING NEW INFECTIONS AND ENSURING THAT HIV-POSITIVE PEOPLE RECEIVE CARE, ARE RETAINED IN ACTIVE CARE, AND REMAIN VIRALLY SUPPRESSED. FINALLY, TAG'S HIV PROJECT IS DEVELOPING A COHORT OF CASE STUDIES ON BEST PRACTICES IN COMMUNITY MOBILIZATION AND HOW THEY AFFECT THE TREATMENT AND CARE OF BOTH PEOPLE WITH HIV AND THOSE WHO ARE HIV-NEGATIVE. FINALLY, THE HIV PROJECT WORKS WITH GLOBAL AND DOMESTIC PARTNERS FOR UNIVERSAL ACCESS TO HIGH-QUALITY HIV PREVENTION, TREATMENT, AND CARE PROGRAMS. |
| FORM 990, PART III, LINE 4C | HEPATITIS C VIRUS PROJECT: HEPATITIS C-RELATED LIVER DISEASE IS A LEADING CAUSE OF DEATH AMONG HIV-POSITIVE PEOPLE IN THE UNITED STATES AND EUROPE. GLOBALLY, 5 MILLION HIV-POSITIVE PEOPLE ARE COINFECTED WITH THE HEPATITIS C VIRUS (HCV), WHILE OVER 175 MILLION HAVE HCV ALONE. HIV WORSENS HCV DISEASE PROGRESSION AND OUTCOMES. TAG'S HEPATITIS/HIV PROJECT REVIEWS THE STATE OF RESEARCH ON HCV MONOINFECTION AND COINFECTION. IT ADVOCATES FOR BETTER AND SAFER TREATMENTS, MORE ADVANCED CLINICAL TRIAL DESIGNS, AND ACCESS TO CURATIVE TREATMENT FOR ALL AFFECTED COMMUNITIES. IT CONTINUALLY MONITORS STANDARDS OF CARE FOR PEOPLE WITH HCV MONOINFECTION AND COINFECTION. THE PROJECT WORKS IN COLLABORATION WITH THE HCV AND HIV COMMUNITIES, SCIENTISTS, GOVERNMENT, AND DRUG COMPANIES TO PROVIDE LIFESAVING INFORMATION AND SAFER, MORE TOLERABLE, AND CURATIVE HEPATITIS TREATMENTS UNIVERSALLY AVAILABLE. IN 2012, THE PROJECT EXPANDED ITS SCOPE TO TAKE ON THE CHALLENGE OF ACCELERATING INTERNATIONAL ACCESS TO CUTTING-EDGE TREATMENT FOR HCV. WITH THE ADVENT OF NEW SHORT-COURSE ALL-ORAL CURES FOR HCV, THE PROJECT HAS BEEN COLLABORATING WITH PARTNERS GLOBALLY TO HASTEN UNIVERSAL, AFFORDABLE ACCESS TO THESE CURATIVE MEDICATIONS. IN 2014, THE PROJECT WAS INSTRUMENTAL IN BUILDING A GLOBAL COALITION OF ACTIVISTS IN LOW- AND MIDDLE-INCOME COUNTRIES WHO ARE ADVOCATING FOR ACCESS TO THESE CURES AND FOR CARE FOR ALL PEOPLE WITH HCV. |
| FORM 990, PART VI, SECTION B, LINE 11 | A DRAFT OF FORM 990 WAS SENT TO MEMBERS OF BOARD OF DIRECTORS FOR REVIEW AND APPROVAL |
| FORM 990, PART VI, SECTION B, LINE 12C | CONFLICT OF INTEREST POLICY REQUIRES BOARD MEMBERS AND KEY STAFF TO COMPLETE AN ANNUAL DISCLOSURE STATEMENT. THE RELATED INDIVIDUAL WILL BE EXCLUDED FROM THE DISCUSSION AND THE VOTING PROCESS. |
| FORM 990, PART VI, SECTION B, LINE 15 | COMPENSATION FOR ALL EMPLOYEES IS REVIEWED AND APPROVED BY THE EXECUTIVE DIRECTOR. COMPENSATION FOR THE EXECUTIVE DIRECTOR IS REVIEWED AND APPROVED BY THE BOARD OF DIRECTORS. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE ORGANIZATION'S GOVERMENT DOCUMENTS ARE AVAILABLE UPON REQUEST. ANNUAL REPORTS ARE AVAILABLE ON THE ORGANIZATION'S WEBSITE. |
| FORM 990, PART XII, LINE 2C | THE PROCESS HAS NOT CHANGED SINCE THE PRIOR YEAR. |
| Software ID: | |
| Software Version: |